Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Economia
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Elis: Disclosure of the number of shares forming the capital and of the total…
DECLARATION DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE AU 31 DECEMBRE 2024 Article L. 233-8-II du Code de Commerce Article 223-16 du Règlement général de l'AMFNombre d'actions composant le capital social236 664 445Nombre de droits de vote théoriques269 859 609Nombre de droits de vote exerçables269 674 754Cette déclaration est en ligne sur le site internet d'Eliswww.elis.comDISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITAL...
Nasdaq GlobeNewswire
13/01/2025
Aduro Clean Technologies to Ring the Nasdaq Closing Bell on Friday, January…
Aduro Clean Technologies Inc.(“ Aduro ” or the “ Company ”) (Nasdaq:ADUR ) (CSE:ACT ) (FSE:9D5 ), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21 stcentury, today announced the Company will ring the closing bell at the Nasdaq MarketSite in Times Square, New York, on Friday, January 17, 2025.This event marks a significant milestone for Aduro following...
Nasdaq GlobeNewswire
13/01/2025
ClearView Healthcare Partners Makes Strategic Investment in Epistemic AI to…
ClearView Healthcare Partners Makes Strategic Investment in Epistemic AI to Advance Next-Generation Biomedical AI PlatformClearView Healthcare Partners and Epistemic AI to collaborate to provide better and more efficient insights to the biopharma industry BOSTON, MA and WESTPORT, CT – 13 January 2025:ClearView Healthcare Partners (“ClearView”), the leading life sciences strategic consultancy supporting Pharma and Biotech sponsors globally, today announced a strategic...
Nasdaq GlobeNewswire
13/01/2025
Mastercard and FreedomPay Unlock Global Commerce With New Payment Gateway…
Collaboration Expands Reach to 230+ Acquirers, Streamlining International Transactions for Businesses FreedomPay, a leader in Next Level Commerce™ technologies, today announced a strategic alliance with Mastercard. This collaboration will provide businesses worldwide with a simplified and extended global payment gateway solution, streamlining their ability to connect with acquirers and accept a wider range of payment methods.Utilizing FreedomPay's established presence in North America,...
Nasdaq GlobeNewswire
13/01/2025
Form 8.5 (EPT/RI) - Brand Architekts Group plc
FORM 8.5 (EPT/RI)PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Brand Architekts Group plc ...
Nasdaq GlobeNewswire
13/01/2025
Auction result of Treasury Bills - RIKV 25 0416 - RIKV 25 0820
Series RIKV 25 0416RIKV 25 0820Settlement Date 01/15/202501/15/2025 Total Amount Allocated (MM) 29,93523,300 All Bids Awarded At (Price / Simple interest) 97.918/8.41295.263/8.249 Total Number of Bids Received 1827 Total Amount of All Bids Received (MM) 32,43525,600 Total Number of Successful Bids 1524 Number of Bids Allocated in Full 1524 Lowest Price / Highest Simple Interest Allocated 97.918/8...
Nasdaq GlobeNewswire
13/01/2025
Form 8.5 (EPT/RI) - Warpaint London Plc
FORM 8.5 (EPT/RI)PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Warpaint London Plc ...
Nasdaq GlobeNewswire
13/01/2025
Niels Erik Jakobsen, Managing Director, retires
After nearly 38 years with Jyske Bank - of these almost 16 years on the Group Executive Board - Niels Erik Jakobsen, Managing Director, has decided to retire in the course of the second quarter of 2025.Niels Erik Jakobsen was employed by Jyske Bank on 1 August 1987. He joined the Group Executive Board on 1 September 2009 and has been in charge of e.g. Capital Markets and most recently Personal Clients and Wealth Management. In addition, Niels Erik Jakobsen is Chairman of the Supervisory...
Nasdaq GlobeNewswire
13/01/2025
Global Aftermarket Veteran John Perrin Appointed Vice President, General Manager…
DRiV is one of the world's premier partners to replacement parts distributors and wholesalers, engine rebuilders and vehicle service and repair businesses. The business offers an unparalleled portfolio of more than 30 elite brands, including Monroe ®, MOOG ®, FERODO ®, Wagner™, Champion ®, and Walker ®. DRiV employs more than 9,000 team members worldwide.Perrin, who began his career in 1996 as an aftermarket Territory Sales Manager for Tenneco, has advanced through an impressive...
Nasdaq GlobeNewswire
13/01/2025
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
FORM 8.5 (EPT/RI)PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Poolbeg Pharma Plc ...
Nasdaq GlobeNewswire
13/01/2025
Government Future Financing 2030 Program Signs a Cooperation Agreement with…
“Government Future Financing 2030 Program (Exclusively Managed by Elite Capital & Co. Limited) has signed an EXIM + Finance System Cooperation Agreement in the ICT solutions and engineering services sector with one of the most important and leading specialists in the Egyptian industry, DIGITIZE for Investment and Technology Co., after holding negotiations since July 2024, which culminated in this exceptional event,” Mr. George Matharu said.DIGITIZE (DGTZ.CA) is the only publicly...
Nasdaq GlobeNewswire
13/01/2025
Form 8.5 (EPT/RI) - Brown (N.) Group plc
FORM 8.5 (EPT/RI)PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Brown (N) Group Plc ...
Nasdaq GlobeNewswire
13/01/2025
Iveco Group earns the prestigious Platinum Medal in the EcoVadis Sustainability…
Turin, 13 thJanuary 2025.Iveco Group (EXM: IVG) announces that it has been awarded the Platinum Medal by EcoVadis, one of the foremost providers of business sustainability ratings worldwide. With a score of 85/100, Iveco Group ranks in the top 1% of over 150,000 companies EcoVadis assessed globally over the last year.The Group received the Gold Medal in 2023 and this upgrade to Platinum highlights its commitment to continuous improvement and to integrating Environmental, Social and...
Nasdaq GlobeNewswire
13/01/2025
Transactions in connection with share buyback programme
Company Announcement No. 5/2025 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility management company, announced on 22 February 2024 a new share buyback programme, see company announcement no. 4/2024. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052...
Nasdaq GlobeNewswire
13/01/2025
International Petroleum Corporation Announces Results of Normal Course Issuer…
International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 313,864 IPC common shares (ISIN: CA46016U1084) during the period of January 1 to 10, 2025 under IPC's normal course issuer bid / share repurchase program (NCIB). IPC's NCIB, announced on December 3, 2024, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) No...
Nasdaq GlobeNewswire
13/01/2025
Share buyback programme - week 2
Nasdaq Copenhagen Euronext Dublin London Stock Exchange Danish Financial Supervisory Authority Other stakeholders Date 13 January 2025 Share buyback programme - week 2 The share buyback programme runs in the period 1 February 2024 up to and including 27 January 2025, see company announcement of 31 January 2024. Part I of the programme, for DKK 750 million, was completed on 27 June 2024, see company announcement of 28 June 2024. Part II of the programme, for DKK 775 million and a...
Nasdaq GlobeNewswire
13/01/2025
Transaction in Own Shares
13 thJanuary 2025 PayPoint plc ("PayPoint" or the "Company") Transaction in Own SharesThe Company announces today it has purchased the following number of its ordinary shares of £0.00333 each through Investec Bank plc (“Investec”). Ordinary Shares Date of purchase:10 thJanuary 2025Aggregate number of ordinary shares purchased:10,092Lowest price per share (pence):696.00Highest price per share (pence):728.00Weighted average price per day (pence):...
Nasdaq GlobeNewswire
13/01/2025
EUR 150 million share buyback program begins
The Hague - January 13, 2025 - Aegon today begins a EUR 150 million share buyback that was announced on November 15, 2024. The share buyback is expected to be completed by June 30, 2025, barring unforeseen circumstances. The new EUR 150 million share buyback program will include an amount of about EUR 40 million to meet Aegon's obligations resulting from the share-based compensation plans for senior management. Aegon intends to cancel the remainder of the repurchased shares resulting from...
Nasdaq GlobeNewswire
13/01/2025
Prestigious Scientific Event: Hong Kong Laureate Forum 2025
Calling Outstanding Young Scientists in Astronomy, Life Science and Medicine, and Mathematical Sciences! / Master) students, as well as undergraduate students aged 35 or below who are pursuing studies or research in Astronomy, Life Science and Medicine, Mathematical Sciences, or other closely related fields. Eligible applicants are encouraged to submit their applications viahttps://application.hklaureateforum.org/registration/.The inaugural Forum offered a world-class platform,...
Nasdaq GlobeNewswire
13/01/2025
Heihe Cold-Area Car Testing Index Released: Anchoring Global Innovation Hubs…
A Media Snippet accompanying this announcement is available by clicking on this link. Against the backdrop of the automotive industry's shift toward electrification, connectivity, intelligence, and shared mobility, China is accelerating its progress towards becoming an automobile powerhouse. Heihe, leveraging its prime natural conditions in the "golden latitude" for ice and snow, has actively developed the cold-area car testing industry. Every year, it attracts a large number of...
Nasdaq GlobeNewswire
13/01/2025
Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific…
Biohaven Ltd.(NYSE: BHVN) and Merus N.V.(Nasdaq:MRUS), today announced a research collaboration and license agreement to co-develop three novel bispecific antibody drug conjugates (ADCs), leveraging Merus' leading Biclonics ®technology platform, and Biohaven's next-generation ADC conjugation and payload platform technologies.Under the terms of the agreement, Biohaven is responsible for the preclinical ADC generation of three Merus bispecific antibodies under mutually agreed research...
Nasdaq GlobeNewswire
13/01/2025
Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma…
Radio-DARPin MP0712 against DLL3, in co-development with Orano Med, to enter first-in-human study in 2025Mesothelin named as second target in Radio-DARPin pipeline, program to be co-developed with Orano MedOrano Med partnership on Radio-DARPins now expanded to 10 programsMP0533 clinical data show improved response rate and depth in cohort 8 with steeper step-up and more frequent dosing; additional dose densification planned in cohort 9, updates expected in 2025CD3...
Nasdaq GlobeNewswire
12/01/2025
Molecular Partners and Orano Med expand partnership to develop Targeted Alpha…
New agreement enables both companies to fuel a broad and innovative pipeline of212 Pb-Radio-DARPin candidates, bringing the total number of programs up to tenExpanded partnership highlights the parties' emerging leadership in targeted alpha therapies (TAT), leveraging Orano Med's expertise in the development of212 Pb-based TAT and vast proprietary supply of212 Pb and Molecular Partners' unique Radio-DARPins as an ideal vector for radiopharmaceuticalsMost advanced212...
Nasdaq GlobeNewswire
12/01/2025
Transaction in Own Shares
Transaction in Own Shares • • • • • • • • • • • • • • • • Shell plc (the 'Company') announces that on 10 January 2025 it purchased the following number of Shares for cancellation.Aggregated information on Shares purchased according to trading venue: Date of purchaseNumber of Shares purchasedHighest price paid Lowest price paidVolume weighted average price paid per shareVenueCurrency10/01/20251,035,000 £26.7400£26.0150£26.3965LSEGBP...
Nasdaq GlobeNewswire
10/01/2025
Altri Comunicati